Market
Obstructive Sleep Apnea (OSA) Market
OSA is a global life-threatening chronic disease that affects nearly a billion people worldwide.¹
0
M
Sufferers worldwide¹
0
X
More common than diabetes²
0
%
Of adults suffer from OSA³
0
%
Of sufferers are undiagnosed³
$
0
B
Cost to USA for undiagnosed OSA cases³
Global OSA Market
Global OSA Market
The most common treatment prescribed for OSA is CPAP (Continuous Positive Airway Pressure), a technology invented over 40 years ago.¹
Treatments Prescribed for Moderate to Severe Diagnosed OSA Patients
Source: Hidden Health Crisis, American Academy of Sleep Medicine
Since CPAP causes many patient complaints¹ and has low adherence rates,1,2 the multi-billion-dollar OSA market is primed for superior OSA treatment technologies, such as the TherapneaTM upper airway support device.
Sources:
Competitive Landscape
Competitive Landscape: Top CPAP Suppliers
 |
 |
 |
 |
 |
|---|---|---|---|---|
|
NYSE:RMD |
TWSE:4106 |
NYSE:PHG |
SSE:600690 |
TYO:3401 |
|
Market Cap:
$35.6B USD |
Market Cap:
$100.1M USD |
Market Cap:
$29.9B USD |
Market Cap:
$37.5B USD |
Market Cap:
$2.4B USD |
|
Market Share:
~21% |
Market Share:
~18% |
Market Share:
~15% |
Market Share:
~13% |
Market Share:
~12% |
Market cap numbers as of Feb. 10, 2022